Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Overexpression of wild type glycine alpha 1 subunit rescues ethanol sensitivity in accumbal receptors and reduces binge drinking in mice
    Published on 2022-09-29
    4 years ago
  • A novel stress-based intervention reduces cigarette use in non-treatment seeking smokers
    Published on 2022-09-29
    4 years ago
  • Compulsion and substance use disorder: potential importance of boundary conditions
    Published on 2022-09-29
    4 years ago
  • Non-sedative cortical EEG signatures of allopregnanolone and functional comparators
    Published on 2022-09-27
    4 years ago
  • Synaptic plasticity as a therapeutic target to modulate circuits in psychiatric disorders
    Published on 2022-09-27
    4 years ago
  • Towards an understanding of psychedelic-induced neuroplasticity
    Published on 2022-09-19
    4 years ago
  • Sex-dependent risk factors for PTSD: a prospective structural MRI study
    Published on 2022-09-16
    4 years ago
« Previous 1 … 140 141 142 143 Next »
Journal of Psychopharmacology
  • Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants
    Published on 2018-09-27
    8 years ago
  • Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats
    Published on 2018-09-27
    8 years ago
  • Anhedonia and depression severity dissociated by dmPFC resting-state functional connectivity in adolescents
    Published on 2018-09-27
    8 years ago
  • Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression
    Published on 2018-09-27
    8 years ago
  • The dose-dependent psychomotor effects of intravenous delta-9-tetrahydrocannabinol (Δ9-THC) in humans
    Published on 2018-09-26
    8 years ago
  • The evolutionary old forebrain as site of action to develop new psychotropic drugs
    Published on 2018-09-26
    8 years ago
  • Differential α2A- and α2C-adrenoceptor protein expression in presynaptic and postsynaptic density fractions of postmortem human prefrontal cortex
    Published on 2018-09-26
    8 years ago
« Previous 1 … 140 141 142 143 144 145 Next »
European Neuropsychopharmacology
  • P.773 Therapeutic potential of bromelain in 6-hydroxydopamine rat model of parkinson’s disease
    Published on 2020-11-25
    5 years ago
  • P.759 Impact of hyperhomocysteinemia and different dietary interventions on cognitive performance in a knock-in mouse model for Alzheimer’s disease
    Published on 2020-11-25
    5 years ago
  • P.868Sociodemographic factors modulate psychopathological response during the COVID-19 state of alarm among the general population in Spain
    Published on 2020-11-25
    5 years ago
  • P.780 Methamphetamine alters gaze behaviour during driving
    Published on 2020-11-25
    5 years ago
  • P.771 Deciphering pharmacological mechanism of neurotrophic activity of steroidal chlorohydrin by proteomic, immunocytochemical and computational approach
    Published on 2020-11-25
    5 years ago
  • P.760 Effects of novel cholinesterase inhibitors on mitochondrial respiration and MAO activity – in vitro study
    Published on 2020-11-25
    5 years ago
  • P.869From anti-emetic to hyper-emetic – cannabinoid hyperemesis syndrome
    Published on 2020-11-25
    5 years ago
« Previous 1 … 140 141 142 143 144 … 166 Next »

   Pharma Pub